Sylvia Strauss

2.5k total citations
19 papers, 1.5k citations indexed

About

Sylvia Strauss is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Sylvia Strauss has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Neurology. Recurrent topics in Sylvia Strauss's work include Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and S100 Proteins and Annexins (4 papers). Sylvia Strauss is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and S100 Proteins and Annexins (4 papers). Sylvia Strauss collaborates with scholars based in Germany, Switzerland and Australia. Sylvia Strauss's co-authors include Thomas Berger, Ursula Ganter, Balázs Volk, Joachim Bauer, Jan Bauer, U. Jonas, Benedikt Volk, Ursula Schreiter-Gasser, Irene Witt and M. Hüll and has published in prestigious journals such as FEBS Letters, Acta Neuropathologica and Neurobiology of Aging.

In The Last Decade

Sylvia Strauss

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Strauss Germany 12 813 689 465 273 207 19 1.5k
Robert E. Mrak United States 8 777 1.0× 733 1.1× 479 1.0× 221 0.8× 187 0.9× 9 1.4k
Ken‐ichiro Fukuchi United States 17 819 1.0× 669 1.0× 760 1.6× 211 0.8× 227 1.1× 30 1.8k
Michael A. Mastrangelo United States 21 968 1.2× 717 1.0× 558 1.2× 234 0.9× 298 1.4× 27 1.8k
Vitaliy Gavrilyuk United States 17 452 0.6× 559 0.8× 659 1.4× 144 0.5× 336 1.6× 22 1.5k
Carla Iarlori Italy 16 378 0.5× 532 0.8× 294 0.6× 192 0.7× 204 1.0× 18 1.2k
Kristina Lindholm United States 9 755 0.9× 428 0.6× 383 0.8× 131 0.5× 240 1.2× 11 1.2k
Frédérique Bard United States 16 1.0k 1.2× 652 0.9× 450 1.0× 162 0.6× 281 1.4× 25 1.6k
W H Civin United States 9 1.4k 1.7× 1.2k 1.7× 554 1.2× 349 1.3× 262 1.3× 14 2.1k
Ken-ichiro Fukuchi United States 25 1.1k 1.4× 522 0.8× 1.1k 2.3× 177 0.6× 343 1.7× 45 2.1k
Brandy Wilkinson United States 8 828 1.0× 474 0.7× 581 1.2× 97 0.4× 248 1.2× 11 1.6k

Countries citing papers authored by Sylvia Strauss

Since Specialization
Citations

This map shows the geographic impact of Sylvia Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Strauss more than expected).

Fields of papers citing papers by Sylvia Strauss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Strauss. The network helps show where Sylvia Strauss may publish in the future.

Co-authorship network of co-authors of Sylvia Strauss

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Strauss. A scholar is included among the top collaborators of Sylvia Strauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Strauss. Sylvia Strauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hüll, M., Thomas Berger, Jan Bauer, Sylvia Strauss, & Balázs Volk. (1996). Inflammatory mechanisms in Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. 246(3). 124–128. 44 indexed citations
2.
Hüll, M., Sylvia Strauss, Thomas Berger, Balázs Volk, & Jan Bauer. (1996). The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behavioural Brain Research. 78(1). 37–41. 98 indexed citations
3.
Hüll, M., Bernd L. Fiebich, Klaus Lieb, et al.. (1996). Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options. Neurobiology of Aging. 17(5). 795–800. 69 indexed citations
4.
Hüell, Michael, Sylvia Strauss, Benedikt Volk, Thomas Berger, & Joachim Bauer. (1995). Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathologica. 89(6). 544–551. 180 indexed citations
5.
Hüell, Michael, Sylvia Strauss, Benedikt Volk, Thomas Berger, & Joachim Bauer. (1995). Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathologica. 89(6). 544–551. 7 indexed citations
6.
Strauss, Sylvia, et al.. (1994). Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Neuroscience Letters. 168(1-2). 193–196. 54 indexed citations
7.
Strauss, Sylvia, et al.. (1994). Production of Proteases fromBrevibacterium Linens. Biocatalysis. 10(1-4). 317–323. 6 indexed citations
8.
Figueiredo, Bonald C., U. Otten, Sylvia Strauss, Balázs Volk, & Dušica Maysinger. (1993). Effects of perinatal hypo- and hyperthyroidism on the levels of nerve growth factor and its low-affinity receptor in cerebellum. Developmental Brain Research. 72(2). 237–244. 35 indexed citations
9.
Ganter, Ursula, Josef Abel, Sylvia Strauss, et al.. (1993). Effects of interleukin-1 and interleukin-6 on metallothionein and amyloid precursor protein expression in human neuroblastoma cells. Journal of Neuroimmunology. 45(1-2). 163–173. 22 indexed citations
10.
Bauer, Jan, Ursula Ganter, Sylvia Strauss, et al.. (1992). The participation of interleukin-6 in the pathogenesis of alzheimer's disease. Research in Immunology. 143(6). 650–657. 86 indexed citations
11.
Bauer, Joseph A., et al.. (1992). Participation of interleukin-6 in the pathogenesis of alzheimer's disease. Neurochemistry International. 21. B1–B1. 1 indexed citations
12.
Strauss, Sylvia, Jan Bauer, Ursula Ganter, et al.. (1992). Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.. PubMed. 66(2). 223–30. 294 indexed citations
13.
Bauer, Joachim, Gerhard König, Sylvia Strauss, et al.. (1991). In‐vitro matured human macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells. FEBS Letters. 282(2). 335–340. 46 indexed citations
14.
Bauer, Joachim, Sylvia Strauss, Ursula Schreiter-Gasser, et al.. (1991). Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices. FEBS Letters. 285(1). 111–114. 413 indexed citations
16.
Rommelspacher, Hans & Sylvia Strauss. (1987). Down-regulation of cerebral beta-adrenoceptors induced by long term administration of antidepressants is prevented by ethanol.. PubMed. 1. 697–701. 8 indexed citations
17.
Strauss, Sylvia & N. Laurian. (1983). Benign and malignant pseudothyroiditis. The Journal of Laryngology & Otology. 97(4). 375–378. 6 indexed citations
18.
Strauss, Sylvia, et al.. (1979). Specific PGF-2 alpha binding by the corpus luteum of the pregnant and non-pregnant mare.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 421–9. 10 indexed citations
19.
Strauss, Sylvia. (1973). The American Myth in Britain. South Atlantic Quarterly. 72(1). 66–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026